HMOX1 and COVID-19: Therefore, activation of the HO-1/CO/H2S axis has the potential to improve the clinical manifestations of COVID-19, and pharmacological treatments based on H2S delivery could once again represent an effective strategy in the treatment of patients with COVID-19 [112].